283 related articles for article (PubMed ID: 19682439)
21. Adenosine Dysfunction in Epilepsy and Associated Comorbidities.
Guo M; Li T
Curr Drug Targets; 2022; 23(4):344-357. PubMed ID: 34602036
[TBL] [Abstract][Full Text] [Related]
22. Astrocyte and Neuronal Pannexin1 Contribute Distinctly to Seizures.
Scemes E; Velíšek L; Velíšková J
ASN Neuro; 2019; 11():1759091419833502. PubMed ID: 30862176
[TBL] [Abstract][Full Text] [Related]
23. Reactive A1 Astrocyte-Targeted Nucleic Acid Nanoantiepileptic Drug Downregulating Adenosine Kinase to Rescue Endogenous Antiepileptic Pathway.
Zhu J; Qiu W; Wei F; Wang Y; Wang Q; Ma W; Xiong H; Cui Y; Li X; Xu R; Lin Y
ACS Appl Mater Interfaces; 2023 Jun; 15(25):29876-29888. PubMed ID: 37334941
[TBL] [Abstract][Full Text] [Related]
24. The role of adenosine in epilepsy.
Weltha L; Reemmer J; Boison D
Brain Res Bull; 2019 Sep; 151():46-54. PubMed ID: 30468847
[TBL] [Abstract][Full Text] [Related]
25. Adenosinergic signaling in epilepsy.
Boison D
Neuropharmacology; 2016 May; 104():131-9. PubMed ID: 26341819
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis.
Williams-Karnesky RL; Sandau US; Lusardi TA; Lytle NK; Farrell JM; Pritchard EM; Kaplan DL; Boison D
J Clin Invest; 2013 Aug; 123(8):3552-63. PubMed ID: 23863710
[TBL] [Abstract][Full Text] [Related]
27. Adenosine Kinase Deficiency in the Brain Results in Maladaptive Synaptic Plasticity.
Sandau US; Colino-Oliveira M; Jones A; Saleumvong B; Coffman SQ; Liu L; Miranda-Lourenço C; Palminha C; Batalha VL; Xu Y; Huo Y; Diógenes MJ; Sebastião AM; Boison D
J Neurosci; 2016 Nov; 36(48):12117-12128. PubMed ID: 27903722
[TBL] [Abstract][Full Text] [Related]
28. Adenosine kinase gene modified mesenchymal stem cell transplantation retards seizure severity and associated cognitive impairment in a temporal lobe epilepsy rat model.
Zhou Q; Zhang N; Wang M; Zhao Q; Zhu S; Kang H
Epilepsy Res; 2024 Feb; 200():107303. PubMed ID: 38306957
[TBL] [Abstract][Full Text] [Related]
29. Comorbidities in Neurology: Is adenosine the common link?
Boison D; Aronica E
Neuropharmacology; 2015 Oct; 97():18-34. PubMed ID: 25979489
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of adenosine kinase in cortical astrocytes and focal neocortical epilepsy in mice.
Shen HY; Sun H; Hanthorn MM; Zhi Z; Lan JQ; Poulsen DJ; Wang RK; Boison D
J Neurosurg; 2014 Mar; 120(3):628-38. PubMed ID: 24266544
[TBL] [Abstract][Full Text] [Related]
31. Glial adenosine kinase--a neuropathological marker of the epileptic brain.
Aronica E; Sandau US; Iyer A; Boison D
Neurochem Int; 2013 Dec; 63(7):688-95. PubMed ID: 23385089
[TBL] [Abstract][Full Text] [Related]
32. The support of adenosine release from adenosine kinase deficient ES cells by silk substrates.
Uebersax L; Fedele DE; Schumacher C; Kaplan DL; Merkle HP; Boison D; Meinel L
Biomaterials; 2006 Sep; 27(26):4599-607. PubMed ID: 16709437
[TBL] [Abstract][Full Text] [Related]
33. Role of the purinergic signaling in epilepsy.
Cieślak M; Wojtczak A; Komoszyński M
Pharmacol Rep; 2017 Feb; 69(1):130-138. PubMed ID: 27915186
[TBL] [Abstract][Full Text] [Related]
34. Computational exploration of vicine - an alkaloid glycoside mediated pathological hallmark of adenosine kinase to promote neurological disorder.
Paramashivam S; Balasubramaniam S; Dhiraviam KN
Metab Brain Dis; 2021 Apr; 36(4):653-667. PubMed ID: 33496919
[TBL] [Abstract][Full Text] [Related]
35. Adenosine kinase facilitated astrogliosis-induced cortical neuronal death in traumatic brain injury.
Jin W; Xu W; Chen J; Zhang X; Shi L; Ren C
J Mol Histol; 2016 Jun; 47(3):259-71. PubMed ID: 26983602
[TBL] [Abstract][Full Text] [Related]
36. Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy.
Gouder N; Fritschy JM; Boison D
Epilepsia; 2003 Jul; 44(7):877-85. PubMed ID: 12823569
[TBL] [Abstract][Full Text] [Related]
37. Astrocytes derived from fetal neural progenitor cells as a novel source for therapeutic adenosine delivery.
Van Dycke A; Raedt R; Verstraete A; Theofilas P; Wadman W; Vonck K; Boison D; Boon P
Seizure; 2010 Sep; 19(7):390-6. PubMed ID: 20688264
[TBL] [Abstract][Full Text] [Related]
38. Silk polymer-based adenosine release: therapeutic potential for epilepsy.
Wilz A; Pritchard EM; Li T; Lan JQ; Kaplan DL; Boison D
Biomaterials; 2008 Sep; 29(26):3609-16. PubMed ID: 18514814
[TBL] [Abstract][Full Text] [Related]
39. Engineering embryonic stem cell derived glia for adenosine delivery.
Fedele DE; Koch P; Scheurer L; Simpson EM; Möhler H; Brüstle O; Boison D
Neurosci Lett; 2004 Nov; 370(2-3):160-5. PubMed ID: 15488315
[TBL] [Abstract][Full Text] [Related]
40. Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts.
Güttinger M; Padrun V; Pralong WF; Boison D
Exp Neurol; 2005 May; 193(1):53-64. PubMed ID: 15817264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
